体外式除細動器の世界市場-2023年～2030年

概要

体外式除細動器は、主に心室細動（速く不規則な心拍）や心室頻拍（致死的な速い心拍）の治療に使用されます。緊急救命装置として、患者の心拍を検出・分析し、電気ショックを与える電池と電極パッドが含まれています。

成人は、心停止時に自動体外式除細動器（AED）を使用して体外式除細動を行うことができます。この装置には、患者の脈拍を確認し、呼吸を整え、電極パッドを配置する方法についての指示が記載されています。AEDは患者の心拍を分析し、ショックが必要かどうかを判断し、ショック後の心肺蘇生を指導します。このプロセスは、救命士が到着して高度救命処置（ALS）を行うまで続けられます。

AEDはコンピュータ除細動器の一種で、心停止に陥った人の心臓のリズムを自動的に分析します。適切な場合には、心臓に電気ショックを与えて正常なリズムを回復させる。AEDシステムには、バッテリーやパッド電極などの付属品が含まれます。これらは、AEDが人の心臓リズムを検出・解釈し、必要に応じて電気ショックを与えるために必要なものです。

市場促進要因：市場抑制要因

不整脈の増加

不整脈は一般的なものであるが、種類によってはより一般的なものもあります。最も一般的なものは早発性心房複合体（PAC）と心房細動です。心房細動は、65歳未満のアメリカ人の約50人に1人、65歳以上のアメリカ人の約10人に1人が罹患しています。心室性不整脈の発生率はさまざまです。ある研究では、心室性不整脈は成人10万人あたり48人（約2,100人に1人）にみられました。高齢者では、心室性不整脈は既知の危険因子のない人では100人中2-3人に、冠動脈疾患（CAD）のある人では100人中15-16人に起こる。

政府、規制機関、ヘルスケア組織による支援政策の増加が、予測期間中の市場の活性化につながると予想されます。例えば、IRC（イタリア蘇生協議会）は、イタリアにおけるAEDに関する法律案が2021年7月に議会の社会問題委員会で承認されたと報告しています。

さらに、世界の体外式除細動器市場は、技術的進歩、新規製品の発売、主要プレイヤーとの協業などの様々な要因によって、予測期間中の市場成長をさらに促進させるでしょう。

市場力学：市場抑制要因

製品リコールは、予測期間中の市場成長率を阻害する主な要因の一つです。例えば、2023年7月、メドトロニック社は、高電圧治療中にエネルギー出力が低い、または出力されないリスクがあるとして、ガラス製フィードスルーを備えた植込み型除細動器（ICD）および心臓再同期療法除細動器（crt-ds）をリコールしました。

また、厳しい規制や突然の心停止（SAC）に対する認識と早期是正措置の欠如といった要因も、予測期間における市場の成長を阻害する可能性があります。さらに、サイバーセキュリティも除細動器市場における主要な懸念事項です。新世代の植え込み型除細動器は技術的に進んでおり、遠隔データ転送が可能です。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 不整脈の有病率の上昇
    • 各国政府による支援政策の増加
  • 抑制要因
    • 製品リコール
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• ロシア・ウクライナ戦争の影響分析
• DMI意見

第6章 COVID-19分析

第7章 製品タイプ別

• 自動体外式除細動器
• 手動式体外式除細動器
• 装着型除細動器

第8章 技術別

• 単相除細動
• 二相除細動

第9章 エンドユーザー別

• 病院
• 診療所
• 在宅医療サービス
• 外来手術センター

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• Koninklijke Philips N.V
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Advin Health Care
• ZOLL Medical Corporation
• Defibtech, LLC.
• Stryker
• ClJ Medical System Inc.
• Avive Solutions, Inc
• Schiller AG
• MEDIANA Co., Ltd
• ViVest Medical Technology Co

第13章 付録

Overview

An external defibrillator is mainly used to treat ventricular fibrillation (fast and irregular heartbeat) and ventricular tachycardia (fatal rapid heartbeat). As an emergency life-saving device, it includes batteries and electrode pads that detect and analyze the patient's heart rhythm and deliver electrical shocks.

Adults can perform external defibrillation using an Automated External Defibrillator (AED) in case of a cardiac arrest. The device provides instructions on how to check the patient's pulse, breathe, and place electrode pads. The AED analyses the patient's heart rhythm, determines if a shock is needed, and guides through cardiopulmonary resuscitation after the shock. The process continues until help arrives to provide advanced life support (ALS) treatment.

AEDs are a type of computerized defibrillator that automatically analyzes the heart rhythm in people who are experiencing cardiac arrest. When appropriate, it delivers an electrical shock to the heart to restore its normal rhythm. The AED system includes accessories, such as a battery and pad electrodes, that are necessary for the AED to detect and interpret a person's heart rhythm and deliver an electrical shock if needed.

Market Dynamics: Drivers and Restraints

Rise in the Prevalence of cardiac arrhythmias

Arrhythmias are common, but some types are more common than others. The most common are premature atrial complexes (PACs) and atrial fibrillation. Atrial fibrillation affects about 1 in 50 Americans under the age of 65 and about 1 in 10 Americans over age 65. The incidence of ventricular arrhythmias varies widely. In one study, ventricular arrhythmias occurred in 48 per 100,000 adults (approximately 1 in 2,100 people). In older adults, ventricular arrhythmias occur in 2-3 out of 100 people who do not have any known risk factors, and in 15-16 in 100 people who have coronary artery disease (CAD).

An increasing number of supportive policies by governments, regulatory bodies, and healthcare organizations is anticipated to fuel the market over the forecast period. For example, the IRC (Italian Resuscitation Council) reported that the proposed law on AEDs in Italy was approved by the social affairs commission of the chamber in July 2021.

Furthermore, the global external defibrillators market is driven by various factors like technological advancements, novel product launches, and collaboration with key players will further drive the market growth during the forecast period.

Market Dynamics: Restraint

Product recalls is one of the major factor that hampers the market growth rate during the forecast period. For instance, in July 2023, Medtronic recalled implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy defibrillators (crt-ds) with glassed feedthrough for risk of low or no energy output during high voltage therapy.

Also, factors such as stringent regulations and lack of awareness and early corrective measures about Sudden Cardiac Arrest (SAC) may hinder the growth of the market over the forecast period. Moreover, Cybersecurity is another major concern in the defibrillators market. The new generation of implantable defibrillators is technologically advanced, allowing for remote data transfer.

Segment Analysis

The global external defibrillators is segmented based on product type, technology, end-user and region.

The automated external defibrillators segment from the product type accounted for approximately 41.2% of the market share

The automated external defibrillators segment from the product type accounted for 41.2% and it is expected to be dominated during the forecast period. An automated external defibrillator AED is a portable medical device that delivers a shock to the heart through the chest wall in order to restore normal heart rhythm. AEDs are used to treat victims of sudden cardiac arrest (SCA), which is when the heart stops beating unexpectedly. When someone who is suffering from life-threatening arrhythmias goes into sudden cardiac arrest, time is critical.

Automated external defibrillators (AED) are mostly found in public access settings and are meant to be used by non-medical personnel. If someone suffers sudden cardiac arrest, people nearby can provide CPR and use an AED before the ambulance arrives. When turned on, the AED will give the user step-by-step directions to deliver a shock if needed. The person using the AED needs to follow the instructions and the AED will start functioning automatically. This increases the demand for the AED and accelerates the segment's growth.

For instance, in March 2023, Safe Life acquired Coro Medical and AED.us, a national market player in automated external defibrillator (AED) sales and services, to expand life-saving equipment and services across the United States.

Furthermore, in January 2023, Avive Solutions received FDA approval for its Handheld automated external defibrillator with unique capabilities. Avive Connect AED combines cellular and WiFi connectivity, GPS technology, remote maintenance, and extreme portability in the handheld device.

Geographical Analysis

North America accounted for approximately 38.4% of the market share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to the supportive regulations to increase the availability of public access AEDs, and the high adoption of external defibrillators at healthcare facilities. Many national organizations in the U.S., including the American Heart Association (AHA), recommend the implementation of comprehensive Public Access Defibrillation (PAD) programs.

For instance, in June 2020, Royal Philips, a global leader in health technology, stated that the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration has granted premarket approval (PMA) for the company's HeartStart FR3 and HeartStart FRx automated external defibrillators (AEDs), and their supporting accessories, including batteries and pads.

COVID-19 Impact Analysis

COVID-19 had a substantial impact on the global external defibrillators market arrhythmias were observed in many COVID patients, but in-hospital defibrillator facilities helped save their lives. Due to the virus outbreak, many surgical procedures were cancelled or postponed, depending on the criticality of the patient. This resulted in losses for companies.

COVID-19 also impacted various stages of the value chain, primarily due to strict lockdowns imposed by the governments of most countries. The turnaround time for the delivery of products and services was also affected due to countries' newer packaging protocols and lockdown measures. All these factors negatively impacted the manufacturing and supply chain of the defibrillators market.

Competitive Landscape

The major global players in the external defibrillators market include: Koninklijke Philips N.V, Advin Health Care, ZOLL Medical Corporation, Defibtech, LLC., Stryker, ClJ Medical System Inc., Avive Solutions, Inc, Schiller AG, MEDIANA Co., Ltd, ViVest Medical Technology Co and among others.

Key Developments

• In January 2023, Avive Solutions, Inc., received U.S. Food and Drug Administration (FDA) pre-market approval (PMA)-- the agency's highest level of approval- for its Avive AED, a unique automated external defibrillator.
• In April 2022, Kestra Medical Technologies stated that the company's ASSURE Wearable Cardioverter Defibrillator (WCD) system is effective at reducing false-positive shock alarms according to results of the ASSURE clinical evaluation detection and safety study published in the journal of cardiovascular electrophysiology.

Why Purchase the Report?

• To visualize the global external defibrillators market segmentation-based product type, technology, end-user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development
• Excel data sheet with numerous data points of external defibrillators market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global external defibrillators market report would provide approximately 69 tables, 70 figures, and 185 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Technology
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Driver
    • 4.1.1.1. Rise in the prevalence of cardiac arrhythmias
    • 4.1.1.2. Increasing number of supportive policies by governments
  • 4.1.2. Restraints
    • 4.1.2.1. Product recalls
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Russia-Ukraine War Impact Analysis
• 5.6. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Automated External Defibrillators *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Manual External Defibrillators
• 7.4. Wearable Cardioverter Defibrillators

8. By Technology

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 8.1.2. Market Attractiveness Index, By Technology
• 8.2. Monophasic Defibrillation *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Biphasic Defibrillation

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Clinics
• 9.4. Home Care Services
• 9.5. Ambulatory Surgical Centers

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Koninklijke Philips N.V
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Advin Health Care
• 12.3. ZOLL Medical Corporation
• 12.4. Defibtech, LLC.
• 12.5. Stryker
• 12.6. ClJ Medical System Inc.
• 12.7. Avive Solutions, Inc
• 12.8. Schiller AG
• 12.9. MEDIANA Co., Ltd
• 12.10. ViVest Medical Technology Co

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us